Average Co-Inventor Count = 4.04
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Fujisawa Pharmaceutical Company, Ltd. (39 from 940 patents)
2. Astellas Pharma Gmbh (2 from 417 patents)
3. University of Kentucky Research Foundation (1 from 881 patents)
42 patents:
1. 7317107 - Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
2. 7064144 - Imidazole derivatives as adenosine deaminase inhibitors
3. 6908940 - Imidazole compounds and their use as adenosine deaminase inhibitors
4. 6596738 - Heterocyclic compound, composition and method for inhibiting adenosine deaminase
5. 6359145 - Imidazole compounds
6. 5739130 - Heterotricyclic derivatives, process for their preparation and
7. 5670533 - Pyrazole derivatives, processes for preparation thereof and
8. 5583135 - Heterotricyclic derivatives, process for their preparation and
9. 5571810 - Thiophene derivatives
10. 5550147 - Pyrazole derivatives, processes for preparation thereof and
11. 5134142 - Pyrazole derivatives, and pharmaceutical composition comprising the same
12. 5034417 - New alkanesulfonanilide derivatives, processes for preparation thereof
13. 4923998 - Cephem and cepham compounds and processes for preparation thereof
14. 4885297 - Thiazolopyridine compounds, processes for the preparation thereof and
15. 4866091 - Alkanesulfonanilide derivatives, processes for preparation thereof and